These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 20304474)

  • 1. Utility of peanut-specific IgE levels in predicting the outcome of double-blind, placebo-controlled food challenges.
    van Nieuwaal NH; Lasfar W; Meijer Y; Kentie PA; Flinterman AE; Pasmans SG; Knulst AC; Hoekstra MO
    J Allergy Clin Immunol; 2010 Jun; 125(6):1391-2. PubMed ID: 20304474
    [No Abstract]   [Full Text] [Related]  

  • 2. Prediction of anaphylaxis during peanut food challenge: usefulness of the peanut skin prick test (SPT) and specific IgE level.
    Wainstein BK; Studdert J; Ziegler M; Ziegler JB
    Pediatr Allergy Immunol; 2010 Jun; 21(4 Pt 1):603-11. PubMed ID: 20444154
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Does severity of low-dose, double-blind, placebo-controlled food challenges reflect severity of allergic reactions to peanut in the community?
    Hourihane JO; Grimshaw KE; Lewis SA; Briggs RA; Trewin JB; King RM; Kilburn SA; Warner JO
    Clin Exp Allergy; 2005 Sep; 35(9):1227-33. PubMed ID: 16164452
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peanut epitopes for IgE and IgG4 in peanut-sensitized children in relation to severity of peanut allergy.
    Flinterman AE; Knol EF; Lencer DA; Bardina L; den Hartog Jager CF; Lin J; Pasmans SG; Bruijnzeel-Koomen CA; Sampson HA; van Hoffen E; Shreffler WG
    J Allergy Clin Immunol; 2008 Mar; 121(3):737-743.e10. PubMed ID: 18234310
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differences among heat-treated, raw, and commercial peanut extracts by skin testing and immunoblotting.
    Maleki SJ; Casillas AM; Kaza U; Wilson BA; Nesbit JB; Reimoneqnue C; Cheng H; Bahna SL
    Ann Allergy Asthma Immunol; 2010 Dec; 105(6):451-7. PubMed ID: 21130383
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modified oral food challenge used with sensitization biomarkers provides more real-life clinical thresholds for peanut allergy.
    Blumchen K; Beder A; Beschorner J; Ahrens F; Gruebl A; Hamelmann E; Hansen G; Heinzmann A; Nemat K; Niggemann B; Wahn U; Beyer K
    J Allergy Clin Immunol; 2014 Aug; 134(2):390-8. PubMed ID: 24831438
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Moving from peanut extract to peanut components: towards validation of component-resolved IgE tests.
    Aalberse JA; Meijer Y; Derksen N; van der Palen-Merkus T; Knol E; Aalberse RC
    Allergy; 2013 Jun; 68(6):748-56. PubMed ID: 23621551
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel immunoassay using recombinant allergens simplifies peanut allergy diagnosis.
    Codreanu F; Collignon O; Roitel O; Thouvenot B; Sauvage C; Vilain AC; Cousin MO; Decoster A; Renaudin JM; Astier C; Monnez JM; Vallois P; Morisset M; Moneret-Vautrin DA; Brulliard M; Ogier V; Castelain MC; Kanny G; Bihain BE; Jacquenet S
    Int Arch Allergy Immunol; 2011; 154(3):216-26. PubMed ID: 20861643
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Allergy or tolerance in children sensitized to peanut: prevalence and differentiation using component-resolved diagnostics.
    Nicolaou N; Poorafshar M; Murray C; Simpson A; Winell H; Kerry G; Härlin A; Woodcock A; Ahlstedt S; Custovic A
    J Allergy Clin Immunol; 2010 Jan; 125(1):191-7.e1-13. PubMed ID: 20109746
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictive value of skin prick tests using recombinant allergens for diagnosis of peanut allergy.
    Astier C; Morisset M; Roitel O; Codreanu F; Jacquenet S; Franck P; Ogier V; Petit N; Proust B; Moneret-Vautrin DA; Burks AW; Bihain B; Sampson HA; Kanny G
    J Allergy Clin Immunol; 2006 Jul; 118(1):250-6. PubMed ID: 16815163
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predicting outcome of repeat milk, egg, or peanut oral food challenges.
    Mudd K; Paterakis M; Curtin-Brosnan J; Matsui E; Wood R
    J Allergy Clin Immunol; 2009 Nov; 124(5):1115-6. PubMed ID: 19895997
    [No Abstract]   [Full Text] [Related]  

  • 12. The use of serum-specific IgE measurements for the diagnosis of peanut, tree nut, and seed allergy.
    Maloney JM; Rudengren M; Ahlstedt S; Bock SA; Sampson HA
    J Allergy Clin Immunol; 2008 Jul; 122(1):145-51. PubMed ID: 18502490
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peanut component Ara h 8 sensitization and tolerance to peanut.
    Asarnoj A; Nilsson C; Lidholm J; Glaumann S; Östblom E; Hedlin G; van Hage M; Lilja G; Wickman M
    J Allergy Clin Immunol; 2012 Aug; 130(2):468-72. PubMed ID: 22738678
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Parental anxiety before and after food challenges in children with suspected peanut and hazelnut allergy.
    Zijlstra WT; Flinterman AE; Soeters L; Knulst AC; Sinnema G; L'Hoir MP; Pasmans SG
    Pediatr Allergy Immunol; 2010 Mar; 21(2 Pt 2):e439-45. PubMed ID: 19694978
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Basophil allergen threshold sensitivity, CD-sens, IgE-sensitization and DBPCFC in peanut-sensitized children.
    Glaumann S; Nopp A; Johansson SG; Rudengren M; Borres MP; Nilsson C
    Allergy; 2012 Feb; 67(2):242-7. PubMed ID: 22126416
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety of open food challenges in the office setting.
    Mankad VS; Williams LW; Lee LA; LaBelle GS; Anstrom KJ; Burks AW
    Ann Allergy Asthma Immunol; 2008 May; 100(5):469-74. PubMed ID: 18517080
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peanut allergy--a tough nut to crack.
    Zuidmeer L
    Int Arch Allergy Immunol; 2011; 154(3):181-2. PubMed ID: 20861638
    [No Abstract]   [Full Text] [Related]  

  • 18. Double-blind placebo-controlled challenges for peanut allergy the efficiency of blinding procedures and the allergenic activity of peanut availability in the recipes.
    van Odijk J; Ahlstedt S; Bengtsson U; Borres MP; Hulthén L
    Allergy; 2005 May; 60(5):602-5. PubMed ID: 15813803
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Determination of no-observed-adverse-effect levels and eliciting doses in a representative group of peanut-sensitized children.
    Flinterman AE; Pasmans SG; Hoekstra MO; Meijer Y; van Hoffen E; Knol EF; Hefle SL; Bruijnzeel-Koomen CA; Knulst AC
    J Allergy Clin Immunol; 2006 Feb; 117(2):448-54. PubMed ID: 16461147
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Skin prick testing and peanut-specific IgE can predict peanut challenge outcomes in preschoolchildren with peanut sensitization.
    Johannsen H; Nolan R; Pascoe EM; Cuthbert P; Noble V; Corderoy T; Franzmann A; Loh R; Prescott SL
    Clin Exp Allergy; 2011 Jul; 41(7):994-1000. PubMed ID: 21429048
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.